Clinical trials
Cervical Lesion clinical trials
Below are recruiting cervical lesion clinical trials, each written for real people, not researchers. We’re tracking 27 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06658405RecruitingPhase 2
HPV vaccine after cervical lesion treatment
This trial tests whether an HPV vaccine (Gardasil 9) can help women over 45 who still have HPV after treatment for a high-grade cervical lesion. It compares vaccinated and unvaccinated patients to see if vaccination lowers the risk of the lesion coming back.
LilleAges 45 years+ - NCT06515301Recruiting
Improving follow-up after cervical precancer treatment
This study in Ethiopia looks at ways to help women stay on track with follow-up visits after treatment for cervical precancer. It tests simple support methods to improve adherence.
Silte, Southern EthiopiaAges 25–49 - NCT06276309Recruiting
Protein study of cervical neuroendocrine tumors
This study looks at the proteins in cervical neuroendocrine tumors to understand how they behave and how they affect long-term outcomes. It aims to find new markers that could help predict prognosis and guide treatment.
Fuzhou, FujianAges Any age - NCT05405270Recruiting
Testing how well imiquimod works for abnormal cervix cell changes
This study looks for ways to predict who will respond to imiquimod cream for precancerous cervical cell changes (CIN2 or CIN3). Results may help doctors choose the best treatment approach and better plan follow-up.
BredaAges 18 years+ - NCT07480902Recruiting
Comparing two tests for cervical cancer detection
This trial compares a liquid-based cytology test with a molecular screening test to find early changes in the cervix that could lead to cancer. It may help you understand which test is better at detecting these changes before they become serious.
Mexico City, Mexico CityAges 18–85 - NCT05818774Recruiting
Different types of neck nerve ablation for chronic pain relief
This trial compares two ways of using radiofrequency heat to treat a specific set of neck pain nerves (the “cervical medial branch nerves”). It may help people with long-lasting neck pain who did not improve with standard treatments and who respond to diagnostic nerve blocks.
Toronto, OntarioAges 18–85 - NCT06052033Recruiting
Light therapy vs. laser for persistent cervical changes with HPV
This study compares two treatments—photodynamic therapy using a special light-activated cream and a CO2 laser—to see which works better for clearing low-grade cervical changes caused by a long-lasting high-risk HPV infection. The goal is to find a safe, effective option for women who have had this condition for over a year.
Wenzhou, ZhejiangAges 18–65 - NCT06982976Recruiting
Light therapy for abnormal cervical or vaginal cells
This trial tests a light-based treatment (photodynamic therapy) for high-grade or persistent low-grade abnormal cells in the cervix or vagina. It aims to destroy these cells without surgery, which may be an option for patients who want to avoid more invasive procedures.
Beijing, Beijing MunicipalityAges 18–65 - NCT02743832Recruiting
Personalized surgery planning for early mouth cancer
This study helps doctors plan surgery more individually for early-stage oral (mouth) squamous cell carcinoma. It focuses on using tumor features found during evaluation to guide surgical decisions, aiming to improve treatment accuracy.
Guangzhou, GuangdongAges 20–70 - NCT04057924Recruiting
Watchful waiting for certain abnormal cells in the cervix
This trial checks whether “therapy abstention” (not treating right away) and close monitoring is safe for certain high-grade cervical cell changes. It may help some people avoid immediate procedures while still catching any progression early.
BordeauxAges 18 years+ - NCT05938192Recruiting
Treatments for HPV-related genital tract changes
This trial studies treatment approaches for conditions caused by human papillomavirus (HPV) in the female genital tract. It may help people whose HPV-related disease is being evaluated for new or combined treatment options.
Milan, LombardyAges 18 years+ - NCT07435376RecruitingPhase 2
Targeted radiation boost for bulky cervical cancer
This trial tests adding an extra, targeted radiation dose directly into the tumor for women with bulky cervical cancer, alongside standard chemoradiation. It aims to improve local control without increasing side effects.
Seongnam-si, Gyeonggi-doAges 19–80 - NCT04783805Recruiting
Watch-and-wait treatment for abnormal cervix cells before future pregnancy
This trial studies a “conservative” (less immediate) approach to a specific abnormal cervix finding to see if it can be managed safely for people who want future pregnancies. It uses close follow-up visits instead of immediate procedures for certain results.
BarcelonaAges Any age - NCT06393699Recruiting
Comparing fillings for worn spots on teeth
This study tests two types of tooth-colored fillings and a special glue for repairing worn spots on the sides of teeth near the gumline. It aims to see which material works best and lasts longest.
CairoAges 18–65 - NCT07009327Recruiting
Photodynamic therapy for CIN3
This trial tests a light-based treatment called photodynamic therapy for women with moderate to severe cervical changes (CIN3). It aims to destroy abnormal cells while saving healthy tissue.
BeijingAges 18–65 - NCT06463938Recruiting
Laser vs. Laser plus paste for tooth sensitivity
This trial tests two treatments for tooth sensitivity: a laser device (Lasotronix) alone or combined with a special paste (CPP-ACP). The goal is to find which treatment works better to reduce pain from hot, cold, sweet, or touch.
Karachi, SindhAges 25–65 - NCT07687654Recruiting
Gum recession repair with tooth-colored fillings
This study tests whether placing a tooth-colored filling in a cavity near the gum line can help cover exposed roots when combined with a common gum graft procedure. It may be an option for people who need both a filling and gum recession surgery.
Adıyaman, MerkezAges 18–65 - NCT06147388Recruiting
Can cervical precancer heal on its own?
This study watches to see if early precancerous cells (CIN 2 or 3) on the cervix can go away without treatment, especially in women under 40. It helps doctors understand who might avoid surgery.
PragueAges 18–40 - NCT06967740Recruiting
Precancerous Lesions of the Cervix: Better Care Options
This study looks at better ways to manage early precancerous changes in the cervix (called high-grade lesions) without surgery. It aims to find which approaches work best for women who have not been vaccinated against HPV.
PragueAges 18–46 - NCT07572396RecruitingPhase 2
HPV treatment with vaginal suppositories for mild cervical changes
This study tests a new vaginal medication (Dysplasix) to treat mild cervical cell changes caused by high-risk HPV. The goal is to see if this treatment can help your body clear the virus and prevent these changes from getting worse.
Shatin, New TerritoriesAges 18–65 - NCT04266093Enrolling by invitation
Gene therapy follow-up for adults previously treated at NCI
This study is a follow-up check for people who were previously enrolled in certain NCI gene therapy treatment studies. It helps the research team monitor long-term effects and outcomes after treatment.
Bethesda, MarylandAges 18–120 - NCT07047989RecruitingPhase 1
NWRD09 for HPV-16 related cervical high-grade changes
This trial tests a new drug called NWRD09 for women with high-grade cervical cell changes (CIN 2/3) caused by HPV type 16. The goal is to see if the drug can help clear these abnormal cells without needing surgery.
BeijingAges 18–65 - NCT07175662RecruitingPhase 2
A new treatment for HPV-related high-grade cervical changes
This study tests a new treatment (NWRD08) for women with high-grade cervical changes (CIN 2/3) caused by HPV types 16 or 18. It aims to see if the treatment can help clear the abnormal cells and prevent them from becoming cancer.
Beijing, Beijing MunicipalityAges 18–60 - NCT02329652Recruiting
Bionic stimulation to help arm and trunk movement after spinal injury
This study tests a neuroprosthetic system that uses controlled stimulation to help restore movement in the arm and trunk after a spinal cord injury. If you qualify, it may help you regain practical strength and control for everyday tasks.
Cleveland, OhioAges 17 years+
Hear when a new Cervical Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cervical lesion?
- Yes. Clin2 currently lists 27 recruiting cervical lesion studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cervical lesion trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cervical lesion trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.